Heart and Vessels最新文献_第8页

Authors' reply: bridging the health literacy gap in cardiac rehabilitation through intervention and program design. 作者的答复是：通过干预和方案设计弥合心脏康复方面的健康素养差距。

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-08-01 Epub Date: 2025-11-11 DOI: 10.1007/s00380-025-02621-8

Yuji Kanejima, Kazuhiro P Izawa, Masahiro Kitamura, Kodai Ishihara, Asami Ogura, Ikko Kubo, Hitomi Nagashima, Hideto Tawa, Daisuke Matsumoto, Ikki Shimizu

引用次数: 0

Incidence and clinical significance of inducible perimitral atrial tachycardia in patients with atrial fibrillation. 心房颤动患者诱发性围膜性房性心动过速的发生率及临床意义。

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-08-01 Epub Date: 2026-01-21 DOI: 10.1007/s00380-025-02648-x

Nobuaki Ito, Kenji Yodogawa, Toshiki Arai, Masato Hachisuka, Rei Mimuro, Yuhi Fujimoto, Eiichiro Oka, Kanako Hagiwara, Hiroshi Hayashi, Teppei Yamamoto, Hiroshige Murata, Yu-Ki Iwasaki, Wataru Shimizu, Kuniya Asai

引用次数: 0

Comparison of the clinical utility and diagnostic performance of Murray law-based quantitative flow ratio. 基于默里定律的定量流量比的临床应用及诊断效能比较。

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-08-01 Epub Date: 2026-01-21 DOI: 10.1007/s00380-025-02650-3

Hiroshi Tsunamoto, Yuto Osumi, Takayoshi Toba, Yoichiro Sugizaki, Hiroyuki Kawamori, Takashi Hiromasa, Seigo Iwane, Tetsuya Yamamoto, Shota Naniwa, Yuki Sakamoto, Koshi Matsuhama, Yuta Fukuishi, Kotaro Higuchi, Hiroya Okamoto, Hiromasa Otake

引用次数: 0

Reply to "TAPSE/PASP Ratio as a Prognostic Marker in HFmrEF: A Missed Opportunity?" 回复“TAPSE/PASP比率作为HFmrEF的预后指标：错失的机会？”

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-08-01 Epub Date: 2025-12-02 DOI: 10.1007/s00380-025-02616-5

Manami Ono, Yurika Fukunaga, Atsushi Suzuki, Shota Shirotani, Asaka Mikami, Arisa Nokubo, Makoto Kishihara, Toshiharu Koike, Eiji Shibahashi, Yoshiaki Minami, Ayano Yoshida, Noriko Kikuchi, Hidetoshi Hattori, Tsuyoshi Shiga, Masao Daimon, Kyomi Ashihara, Junichi Yamaguchi

引用次数: 0

Risk of cardiac dysfunction in patients receiving anthracyclines across breast cancer and hematologic malignancies: a single-center retrospective cohort study in Japan. 接受蒽环类药物治疗的乳腺癌和血液恶性肿瘤患者心功能障碍的风险：日本的一项单中心回顾性队列研究

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-08-01 Epub Date: 2026-02-01 DOI: 10.1007/s00380-026-02654-7

Yujiro Homma, Kazuyoshi Kimura, Kenta Sasaki, Yuji Okura, Takeshi Kashimura, Takayuki Inomata, Yasuo Saijo, Qiliang Zhou

引用次数: 0

TAPSE/PASP ratio as a prognostic marker in HFmrEF: a missed opportunity? TAPSE/PASP比值作为HFmrEF的预后指标：错失良机？

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-08-01 Epub Date: 2025-11-29 DOI: 10.1007/s00380-025-02615-6

Xiaoyan Chen, Youai Xie, Meiqing Zhou

引用次数: 0

Prognostic value of preprocedural pulmonary artery to ascending aorta ratio on non-contrast computed tomography in patients undergoing mitral transcatheter edge-to-edge repair. 经二尖瓣边缘修复术患者术前肺动脉与升主动脉比值的非对比ct预测价值。

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-08-01 Epub Date: 2026-01-21 DOI: 10.1007/s00380-025-02649-w

Hiroki Uehara, Toshiyuki Nagai, So Sasaki, Kento Tamano, Toshifumi Tamura, Akinori Takahashi, Takeshi Hamaya, Yuki Mori, Yutaro Yasui, Sakae Takenaka, Satonori Tsuneta, Suguru Ishizaka, Yuta Kobayashi, Atsushi Tada, Taro Temma, Kiwamu Kamiya, Toshihisa Anzai

引用次数: 0

Combined prognostic value of elevated lipoprotein(a) and severe calcification for limb outcomes after endovascular therapy. 血管内治疗后，脂蛋白(a)升高和严重钙化对肢体预后的综合预后价值。

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-07-25 DOI: 10.1007/s00380-026-02738-4

Takeo Horikoshi, Takamitsu Nakamura, Toshiki Takei, Toru Yoshizaki, Manabu Uematsu, Tsuyoshi Kobayashi, Akira Sato

{"title":"Combined prognostic value of elevated lipoprotein(a) and severe calcification for limb outcomes after endovascular therapy.","authors":"Takeo Horikoshi, Takamitsu Nakamura, Toshiki Takei, Toru Yoshizaki, Manabu Uematsu, Tsuyoshi Kobayashi, Akira Sato","doi":"10.1007/s00380-026-02738-4","DOIUrl":"https://doi.org/10.1007/s00380-026-02738-4","url":null,"abstract":"Lipoprotein(a) [Lp(a)] and vascular calcification have each been associated with poor outcomes in lower extremity arterial disease (LEAD). This study investigated whether elevated Lp(a) levels and severe calcification have combined prognostic value for major adverse limb events (MALE) after endovascular therapy (EVT). We retrospectively analyzed 145 patients who underwent EVT. Patients were classified according to the number of Lp(a)/ Peripheral Arterial Calcium Scoring System (PACSS) risk markers: elevated Lp(a) (≥ 30 mg/dL) and PACSS grade 4. The primary endpoint was 1-year MALE incidence. MALE occurred in 17 patients during follow-up. Patients were classified into three groups according to the number of Lp(a)/PACSS risk markers. The cumulative incidence of MALE differed significantly among the three groups (overall P = 0.032). Compared with the 0 risk-marker group, the 1 risk-marker group and the 2 risk-marker group had significantly higher risks of MALE (hazard ratio [HR], 3.175; 95% confidence interval [CI], 1.064-9.475; P = 0.038; and HR, 4.803; 95% CI 1.146-20.128; P = 0.032, respectively). A significant trend toward higher MALE risk was observed with an increasing number of risk markers (P for trend = 0.012). Elevated Lp(a) and severe calcification may identify a subgroup at higher risk of MALE after EVT. Integrating Lp(a) measurement with anatomical assessment by PACSS may provide exploratory insights into risk stratification.","PeriodicalId":12940,"journal":{"name":"Heart and Vessels","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148591330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Aortic calcification and contrast-associated acute kidney injury in patients undergoing urgent coronary angiography. 急诊冠状动脉造影患者的主动脉钙化和造影剂相关急性肾损伤。

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-07-25 DOI: 10.1007/s00380-026-02740-w

Masatsugu Miyagawa, Riku Arai, Yoshikuni Shoji, Ayame Saito, Tatsuya Otake, Yusuke Sasa, Shonosuke Sugai, Kazuki Iso, Wataru Atsumi, Eizo Tachibana, Satoshi Kunimoto, Keisuke Kojima, Yasuo Okumura

{"title":"Aortic calcification and contrast-associated acute kidney injury in patients undergoing urgent coronary angiography.","authors":"Masatsugu Miyagawa, Riku Arai, Yoshikuni Shoji, Ayame Saito, Tatsuya Otake, Yusuke Sasa, Shonosuke Sugai, Kazuki Iso, Wataru Atsumi, Eizo Tachibana, Satoshi Kunimoto, Keisuke Kojima, Yasuo Okumura","doi":"10.1007/s00380-026-02740-w","DOIUrl":"10.1007/s00380-026-02740-w","url":null,"abstract":"Aortic calcification detected on computed tomography (CT) is a marker of systemic atherosclerosis. Its clinical significance in predicting contrast-associated acute kidney injury (CA-AKI) after urgent coronary angiography remains unclear. A total of 140 patients (median age, 73 years [interquartile range 58-81]; female, 24.3%) were included. Calcification was assessed in the ascending aorta, aortic arch/descending aorta, abdominal aorta, coronary arteries, and renal arteries. The primary endpoint was CA-AKI, and the secondary endpoint was serial change in estimated glomerular filtration rate (eGFR) within 3 days after the procedure. CA-AKI occurred in 12.9% of patients. In univariate analysis, calcification of the aortic arch/descending aorta and abdominal aorta was associated with CA-AKI. Calcification of the ascending aorta was not associated with CA-AKI. After multivariable adjustment, calcification of the aortic arch/descending aorta remained associated with CA-AKI. Patients with calcification in these segments showed significantly attenuated improvement in eGFR over time. Among patients undergoing urgent coronary angiography, calcification of the aortic arch/descending aorta and abdominal aorta on CT was associated with CA-AKI and impaired short-term renal recovery. Aortic calcification may provide rapid preprocedural risk stratification.","PeriodicalId":12940,"journal":{"name":"Heart and Vessels","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148591424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Relationship between serum circulating Syndecan-1 levels and myocardial fibrosis and major adverse cardiovascular events in elderly patients with atrial fibrillation. 老年房颤患者血清循环Syndecan-1水平与心肌纤维化及主要心血管不良事件的关系

IF 1.5 4区医学

Heart and Vessels Pub Date : 2026-07-19 DOI: 10.1007/s00380-026-02728-6

Yuncong Ma, Suxia Fang

{"title":"Relationship between serum circulating Syndecan-1 levels and myocardial fibrosis and major adverse cardiovascular events in elderly patients with atrial fibrillation.","authors":"Yuncong Ma, Suxia Fang","doi":"10.1007/s00380-026-02728-6","DOIUrl":"https://doi.org/10.1007/s00380-026-02728-6","url":null,"abstract":"This research investigated the relationship between serum Syndecan-1 levels and myocardial fibrosis (MF) and major adverse cardiovascular events (MACEs) in elderly patients with atrial fibrillation (AF). Elderly patients with AF were divided into MF (n = 162) and N-MF (n = 89) groups. During 5-year follow-up, 78 patients with MACEs formed the MACEs group, and 173 without MACEs formed the N-MACEs group. Spearman correlation analysis was performed. Multivariate Cox regression and Kaplan-Meier curves were conducted, and ROC curves were plotted. Serum Syndecan-1 was elevated in the MF group versus the N-MF group. Serum Syndecan-1 levels in AF patients showed moderate positive correlations with both sST2 (r = 0.569) and PINP (r = 0.446). Serum Syndecan-1 showed diagnostic value for MF in patients with AF, with an AUC of 0.810. Moreover, combined detection with sST2 and PINP further achieved an AUC of 0.872. Serum Syndecan-1 levels were elevated in the MACE group compared to the N-MACEs group, and serum Syndecan-1 demonstrated discriminatory value for 5-year MACEs (AUC = 0.832). Serum Syndecan-1 (HR = 1.049) was independently associated with 5-year MACEs in AF patients. The risk associated with Syndecan-1 was more pronounced in patients with paroxysmalAF. After adjusting for sST2, NT-proBNP, LVEF, and MF, Syndecan-1 was independently associated with MACEs in patients with heart failure (P = 0.021). Elevated serum Syndecan-1 levels are associated with MF and MACEs in AF patients, suggesting its potential value as a biomarker for discriminating MF and MACEs in AF patients.","PeriodicalId":12940,"journal":{"name":"Heart and Vessels","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2026-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148520241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0